246 related articles for article (PubMed ID: 32365191)
1. Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development.
Graepel KW; Kochhar S; Clayton EW; Edwards KE
J Infect Dis; 2020 Jun; 222(2):180-182. PubMed ID: 32365191
[No Abstract] [Full Text] [Related]
2. Rapid COVID-19 vaccine development.
Graham BS
Science; 2020 May; 368(6494):945-946. PubMed ID: 32385100
[No Abstract] [Full Text] [Related]
3. What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist.
Palatnik-de-Sousa CB
Front Immunol; 2020; 11():2173. PubMed ID: 32983183
[No Abstract] [Full Text] [Related]
4. News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.
Peeples L
Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8218-8221. PubMed ID: 32229574
[No Abstract] [Full Text] [Related]
5. Development of an inactivated vaccine candidate for SARS-CoV-2.
Gao Q; Bao L; Mao H; Wang L; Xu K; Yang M; Li Y; Zhu L; Wang N; Lv Z; Gao H; Ge X; Kan B; Hu Y; Liu J; Cai F; Jiang D; Yin Y; Qin C; Li J; Gong X; Lou X; Shi W; Wu D; Zhang H; Zhu L; Deng W; Li Y; Lu J; Li C; Wang X; Yin W; Zhang Y; Qin C
Science; 2020 Jul; 369(6499):77-81. PubMed ID: 32376603
[TBL] [Abstract][Full Text] [Related]
6. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
Front Immunol; 2020; 11():1880. PubMed ID: 32973779
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 shot protects monkeys.
Cohen J
Science; 2020 May; 368(6490):456-457. PubMed ID: 32355008
[No Abstract] [Full Text] [Related]
8. Coronavirus vaccines leap through safety trials - but which will work is anybody's guess.
Callaway E
Nature; 2020 Jul; 583(7818):669-670. PubMed ID: 32710003
[No Abstract] [Full Text] [Related]
9. Coronavirus vaccines get a biotech boost.
Dance A
Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
[No Abstract] [Full Text] [Related]
10. SARS-CoV-2: A New Song Recalls an Old Melody.
Subbarao K
Cell Host Microbe; 2020 May; 27(5):692-694. PubMed ID: 32407706
[TBL] [Abstract][Full Text] [Related]
11. An Effective COVID-19 Vaccine Needs to Engage T Cells.
Sauer K; Harris T
Front Immunol; 2020; 11():581807. PubMed ID: 33117391
[No Abstract] [Full Text] [Related]
12. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.
Lee WS; Wheatley AK; Kent SJ; DeKosky BJ
Nat Microbiol; 2020 Oct; 5(10):1185-1191. PubMed ID: 32908214
[TBL] [Abstract][Full Text] [Related]
13. Developing a low-cost and accessible COVID-19 vaccine for global health.
Hotez PJ; Bottazzi ME
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008548. PubMed ID: 32726304
[No Abstract] [Full Text] [Related]
14. SARS-CoV-2 immunogenicity at the crossroads.
Karamloo F; König R
Allergy; 2020 Jul; 75(7):1822-1824. PubMed ID: 32401346
[No Abstract] [Full Text] [Related]
15. Coronavirus vaccine-associated lung immunopathology-what is the significance?
Bottazzi ME; Strych U; Hotez PJ; Corry DB
Microbes Infect; 2020 Oct; 22(9):403-404. PubMed ID: 32599077
[No Abstract] [Full Text] [Related]
16. Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses.
Gupta T; Gupta SK
Int Immunopharmacol; 2020 Sep; 86():106717. PubMed ID: 32585611
[TBL] [Abstract][Full Text] [Related]
17. Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19.
Coish JM; MacNeil AJ
Microbes Infect; 2020 Oct; 22(9):405-406. PubMed ID: 32590062
[TBL] [Abstract][Full Text] [Related]
18. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
[TBL] [Abstract][Full Text] [Related]
20. What the immune response to the coronavirus says about the prospects for a vaccine.
Ledford H
Nature; 2020 Sep; 585(7823):20-21. PubMed ID: 32811981
[No Abstract] [Full Text] [Related]
[Next] [New Search]
